DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition is a research paper published in Leukemia (2025). On theSindex it has a DataRank of 0.219. It has been cited 3 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0112
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
NCI NIH HHS
Grant: P01 CA108671
National Institutes of Health
Grant: 5T32DK007780-14
Hematopoiesis training grant
National Institutes of Health
Grant: 5K22CA251649-02
Targeting Kinase Inhibitor Induced Signaling Plasticity in Patients with Ph-Like ALL
UK Research and Innovation
Grant: MC_UU_00029/6
Epigenetic Control of Gene Expression in Leukaemia and Haematopoiesis
National Institutes of Health
Grant: 1U01CA232486-01
Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions
National Institutes of Health
Grant: 5U01CA243072-05
Towards rational design of combination therapeutic targets
Fields of Study
MeSH Terms
Keywords